ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1894

Association Of Alleles and Amino Acids Of The Major Histocompatibility Complex Class I Chain-Related Gene A With Psoriatic Disease

Remy Pollock1, Fawnda Pellett2, Renise Ayearst3, Fatima Abji1, Dafna D. Gladman2 and Vinod Chandran2, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: genetics, Major histocompatibility complex (MHC) and psoriatic arthritis

  • Tweet
  • Email
  • Print
Session Information

Session Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

We previously reported associations between alleles of the major histocompatibility complex class I chain-related gene A (MICA) and psoriatic disease that were independent of HLA-B despite their tight linkage disequilibrium. In a larger cohort of patients, we sought to investigate the association with MICAalleles and determine if associations are evident at the amino acid level.

Methods:

Caucasian psoriatic disease patients [786 PsA patients satisfying CASPAR criteria and 358 psoriasis patients without arthritis (PsC)], and 717 unaffected controls were recruited from a large cohort. MICA and HLA-B allelic typing was performed by PCR-SSO. Univariate logistic regressions were performed using MICA and HLA-B alleles as predictor variables for psoriatic disease compared to controls, and PsA compared to PsC. Multivariate logistic regressions used significant MICA alleles with significant HLA-B alleles as covariates. MICA-HLA-B haplotypes were estimated using the EM algorithm and differences between subject groups were analyzed using SNP & Variation Suite 7 software. MICAalleles were converted into amino acids at each polymorphic site of the mature MICA protein and analyzed for differences between groups.

Results:

PsA patients were 58% male, mean age (s.d.) at diagnosis of psoriasis 28 (14.4) years, age at PsA diagnosis 36 (13.0) years, and PASI 5.3 (8.1). Psoriasis patients were 55% male, mean age at diagnosis of psoriasis 30 (16.6) years, and PASI 5.3 (4.9). Controls were 43% male. MICA*002:01, *004, *007:01, *008:01, *009:01, *010:01, *016, *017, and *027 were associated with psoriatic disease compared to controls, and MICA*007:01 and *017 were associated with PsA compared to PsC in univariate analyses (p<0.05). After adjusting for HLA-B alleles, only MICA*016 was independently associated with psoriatic disease (OR=2.1, p<0.01), and MICA*007:01 with PsA (OR=3.2, p=0.04). Haplotypes MICA*016-B*3501 (OR=3.2, p<0.01), MICA*017-B*5701 (OR=2.5, p<0.01) and MICA*002:01-B*3801 (OR=6.5, p<0.01) were among those increased in psoriatic disease compared to controls. Haplotype MICA*007:01-B*2705 (OR=4.1, p<0.01) was increased in PsA compared to PsC, while haplotypes MICA*017-B*5701 (OR=0.54, p<0.01) and MICA*008:01-B*1302 (OR=0.42, p<0.01) were decreased. Methionine at amino acid position 129 (M129), which is present in MICA*002:01, *007:01 and *017, was associated with psoriatic disease compared to controls (OR=1.9, p<0.01), and was strongly associated with amino acids G206, W210, S215, C36, and K173. Arginine at position 91 (R91), which is unique to MICA*017, was decreased in PsA compared with psoriasis patients (OR=0.57, p<0.01).

Conclusion:

We confirmed the HLA-B-independent association of MICA*016 with psoriatic disease, and found a new association between MICA*007:01 and PsA. MICA alleles containing the M129 amino acid are associated with psoriatic disease, while the MICA*017 allele containing the R91 amino acid are protective against PsA in psoriasis patients. Further genetic and structural studies are needed to understand the significance of these findings.


Disclosure:

R. Pollock,
None;

F. Pellett,
None;

R. Ayearst,
None;

F. Abji,
None;

D. D. Gladman,
None;

V. Chandran,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-alleles-and-amino-acids-of-the-major-histocompatibility-complex-class-i-chain-related-gene-a-with-psoriatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences